ArticleDrug design, development and therapy2025

Phase I Trial of Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Advanced Soft Tissue Sarcoma.

Ting Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.